Cellectis (NASDAQ:CLLS) Now Covered by StockNews.com
StockNews.com started coverage on shares of Cellectis (NASDAQ:CLLS – Free Report) in a research note released on Monday morning. The firm issued a sell rating on the biotechnology company’s stock. Cellectis Stock Down 0.5 % Shares of CLLS opened at $1.82 on Monday. The company has a debt-to-equity ratio of 0.39, a quick ratio of […]
More Stories
StockNews.com Initiates Coverage on U.S. Global Investors (NASDAQ:GROW)
StockNews.com initiated coverage on shares of U.S. Global Investors (NASDAQ:GROW – Free Report) in a research report released on Sunday...
TRACON Pharmaceuticals (NASDAQ:TCON) Research Coverage Started at StockNews.com
StockNews.com began coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research report released on Monday morning....
Kellanova (NYSE:K) Now Covered by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Kellanova (NYSE:K – Free Report) in a research report sent to investors on Sunday...
Sotherly Hotels (NASDAQ:SOHO) Coverage Initiated by Analysts at StockNews.com
StockNews.com started coverage on shares of Sotherly Hotels (NASDAQ:SOHO – Free Report) in a research report report published on Sunday...
Transcontinental Realty Investors (NYSE:TCI) Earns Sell Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Transcontinental Realty Investors (NYSE:TCI – Free Report) in a report issued on Monday. The...
American Shared Hospital Services (NYSEAMERICAN:AMS) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of American Shared Hospital Services (NYSEAMERICAN:AMS – Free Report) in a research note issued to...